Inclusion Criteria:
Participant Must:
* Be ≥18 years of age.
* Have Chronic Migraine
* Be willing and able to comply with all study elements, as indicated by written informed consent.
Exclusion Criteria:
Participant Must Not:
* Have diagnosis or history of complicated migraine, basilar migraine, ophthalmoplegic migraine, hemiplegic migraine, or migrainous infarction.
* Progressive neurologic disorder other than migraine.
* Have clinically significant anatomic obstruction that in the investigator's opinion limit access to the posterior nose, including but not limited to severe septal deviation or perforation, nasal polyps, and/or sinonasal tumor.
* Have plans to (or otherwise anticipates the need to) undergo an ENT procedure concurrently or during study.
* Have had previous sinus or nasal surgery within 6 months of study enrollment.
* Have previously undergone radiofrequency, cryotherapy, or other surgical interventions for rhinitis.
* Have started a new migraine medication regimen within 3 months of study enrollment that, according to the manufacturer's labeling, has not yet stabilized.
* Have an acute nasal or sinus infection.
* Have nasal mucosal erosion/ulceration.
* Be on prescribed anticoagulants (eg, warfarin, Plavix) or 325 mg aspirin that cannot be held for an appropriate time before the procedure.
* Have hemophilia.
* Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
* Have numbness of the soft palate, excessive dry eye, excessive dry nose, or other indication of neuro/nerve compromise in the sinonasal cavity.
* Have had previous head and/or neck irradiation.
* Be pregnant.
* Have a physical, neurological, medical, psychiatric condition or situation that, in the investigator's opinion, puts the participant at risk, could confound the study results, or may interfere significantly with the participant's participation in the study.
* Be participating in another clinical research study.
